Trial intelligence / Profile preview

Pharmacokinetics of teriparatide delivery with the MicroCHIPS implantable delivery system

2010-020040-35Phase 4Completed

Sponsor
Microchips Biotech
Start
Aug 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of teriparatide in osteoporosis, sponsored by Microchips Biotech. Primary endpoints: Pharmacokinetic profile of teriparatide after subcutaneous release from implant, Area under the concentration-time curve and 4 more. Started Aug 2010; status: completed.

02

Drugs

teriparatide
03

Conditions

osteoporosis

Beyond the preview

Go deeper on 2010-020040-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-020040-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call